Chefs' Warehouse (CHEF) Is Up 5.7% After Buybacks And Accretive M&A Focus - Has The Bull Case Changed?

Chefs' Warehouse, Inc. -1.67%

Chefs' Warehouse, Inc.

CHEF

57.59

-1.67%

  • The Chefs' Warehouse, Inc. recently reported its fourth-quarter and full-year 2025 results, with sales rising to US$1.14 billion for the quarter and US$4.15 billion for the year, alongside higher annual net income and earnings per share from continuing operations versus 2024.
  • Management also highlighted ongoing share buybacks and a strong pipeline of potential acquisitions, emphasizing disciplined, low‑risk “fold‑in” deals that could enhance territories and complement the company’s existing specialty food platform.
  • Next, we’ll examine how this combination of robust organic growth and cautious, accretive M&A appetite might reshape Chefs’ Warehouse’s investment narrative.

Find 55 companies with promising cash flow potential yet trading below their fair value.

Chefs' Warehouse Investment Narrative Recap

To own Chefs’ Warehouse, you need to believe its specialty focus and customer relationships can translate into consistently growing sales and earnings, while disciplined acquisitions add scale without eroding margins. The latest results show higher full year revenue and earnings per share, but also some quarterly profit pressure, so they do not fundamentally change the near term focus on integration risk and managing cost inflation as the key catalyst and risk pair to watch.

The most relevant recent announcement here is management’s comments on keeping “dry powder” for acquisitions while comparing potential deals with share buybacks. That capital allocation stance sits right at the intersection of the company’s growth catalyst in accretive M&A and the ongoing risk that integrating additional distributors, on top of Italco and the Texas expansion, could strain operations if execution slips.

Yet behind the growth story, investors should also be aware of how rising structural costs could constrain...

Chefs' Warehouse's narrative projects $4.9 billion revenue and $121.9 million earnings by 2028. This requires 7.6% yearly revenue growth and a $52.3 million earnings increase from $69.6 million today.

Uncover how Chefs' Warehouse's forecasts yield a $76.12 fair value, a 12% upside to its current price.

Exploring Other Perspectives

CHEF 1-Year Stock Price Chart
CHEF 1-Year Stock Price Chart

Five members of the Simply Wall St Community currently see Chefs’ Warehouse fair value anywhere between US$38.55 and about US$109.91, illustrating a wide spread of expectations. Against that backdrop, the company’s cautious approach to accretive acquisitions and integration execution could have an outsized impact on how its future performance aligns with any of these views.

Explore 5 other fair value estimates on Chefs' Warehouse - why the stock might be worth as much as 62% more than the current price!

Build Your Own Chefs' Warehouse Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

  • A great starting point for your Chefs' Warehouse research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.
  • Our free Chefs' Warehouse research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Chefs' Warehouse's overall financial health at a glance.

Seeking Other Investments?

Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:

  • Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 30 best rare earth metal stocks of the very few that mine this essential strategic resource.
  • Capitalize on the AI infrastructure supercycle with our selection of the 34 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
  • AI is about to change healthcare. These 24 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.